# Advancing Reperfusion Therapy for Ischemic Stroke: Perfusion-guided Endovascular Intervention for Medium Vessel Occlusion Therapy

> **NCT07323368** · NA · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 568 (estimated)

## Conditions studied

- Stroke Ischemic
- Medium Vessel Occlusions

## Interventions

- **PROCEDURE:** Endovascular treatment
- **DRUG:** Best medical treatment (BMT)

## Key facts

- **NCT ID:** NCT07323368
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-08
- **Primary completion:** 2027-09-30
- **Final completion:** 2028-09-30
- **Target enrollment:** 568 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07323368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07323368, "Advancing Reperfusion Therapy for Ischemic Stroke: Perfusion-guided Endovascular Intervention for Medium Vessel Occlusion Therapy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07323368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*